Musaffa's Global Halal Trading Platform is Here!
Start Investing NowHALO Shariah Compliance
Screening Methodology: AAOIFI
HALAL
Last Updated: November 13, 2025
Report Source: 2025 3rd Quarter Report
Halozyme Therapeutics Inc. Stock Analysis HALO
United States Health Care Mid Cap Report: Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company. The company is headquartered in San Diego, California and currently employs 350 full-time employees. The company went IPO on 2003-01-30. The firm's commercially-validated solution, ENHANZE drug delivery technology with the proprietary enzyme rHuPH20, is used to facilitate the subcutaneous delivery of injected drugs and fluids, with a focus on improving the patient experience with rapid subcutaneous delivery and reduced treatment burden. The firm licenses its technology to biopharmaceutical companies to collaboratively develop products that combine ENHANZE with its partners’ proprietary compounds. The company also develops, manufactures and commercializes, for itself or with partners, drug-device combination products using its advanced auto-injector technologies. The firm has two commercial proprietary products, Hylenex and XYOSTED. The company also has a proprietary ultra-high concentration microparticle formulation technology for biologics, branded Hypercon.
Read More Halozyme Therapeutics Inc (HALO) Chart
Halozyme Therapeutics Inc (HALO) vs CBOE Volatility Index (VIX) Comparative Returns
Analysis of Halozyme Therapeutics Inc (HALO) stock performance compared to the broader market (CBOE Volatility Index (VIX)) across multiple timeframes.
YTD Performance
- Halozyme Therap... (HAL...) 14.29%
- CBOE Volatility Index (VIX) 7.42%
Halozyme Therap... Outperformed CBOE Volatility Index (VIX) by 6.87%
1Y Performance
- Halozyme Therap... (HAL...) 32.37%
- CBOE Volatility Index (VIX) -3.02%
Halozyme Therap... Outperformed CBOE Volatility Index (VIX) by 35.39%
3Y Performance
- Halozyme Therap... (HAL...) 56.66%
- CBOE Volatility Index (VIX) -19.46%
Halozyme Therap... Outperformed CBOE Volatility Index (VIX) by 76.12%
5Y Performance
- Halozyme Therap... (HAL...) 54.33%
- CBOE Volatility Index (VIX) -51.47%
Halozyme Therap... Outperformed CBOE Volatility Index (VIX) by 105.80%
Key Statistics of Halozyme Therapeutics Inc (HALO)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$79.31Volume
2.22MP/E Ratio (TTM)
20.3752 Week Range
Market Cap
8.43BAvg. Volume
1.81MDividend Yield
-Financial Metrics & Statements of Halozyme Therapeutics Inc (HALO)
Super Investors Invested in Halozyme Therapeutics Inc (HALO)
Super Investors are top-performing investors known for their exceptional market strategies and long-term success in wealth creation.
Joel Greenblatt
% Portfolio:
0.08 Recent Activity:271.68%
HOTCHKIS & WILEY
% Portfolio:
0.03 Recent Activity:100.00%
Jefferies Group
% Portfolio:
0.01 Recent Activity:100.00%
Ken Fisher
% Portfolio:
0.01 Recent Activity:0.67%
FAQ's for Halozyme Therapeutics Inc (HALO)
Halal stocks refer to shares of companies that comply with Islamic finance principles, meaning they do not engage in businesses related to alcohol, gambling, pork, or interest-based financial services.
Related Halal Stocks to Halozyme Therapeutics Inc (HALO)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
